Plasma ADAMTS13, von Willebrand Factor (VWF) and VWF Propeptide Profiles in Patients with DIC and Related Diseases

Thrombosis Research

Volumn 129, Issue 5, 2012, Pages 598-602

  Habe, Koji ^a   Wada, Hideo ^a   Ito Habe, Naomi ^a   Hatada, Tsuyoshi ^b   Matsumoto, Takeshi ^a   Ohishi, Kohshi ^a   Maruyama, Kazuo ^a   Imai, Hiroshi ^b   Mizutani, Hitoshi ^a   Nobori, Tsutomu ^a  

^a MIE UNIVERSITY   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ADAMTS13; DIC; Von Willebrand factor (VWF); VWF propeptide

Indexed keywords

VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISSEMINATED INTRAVASCULAR CLOTTING; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVOR; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ADULT; AGED; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PURPURA, THROMBOTIC THROMBOCYTOPENIC; VON WILLEBRAND FACTOR;

EID: 84860436341     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.10.011     Document Type: Article

References (22)

1. K. Soejima, N. Mimura, M. Hirashima, H. Maeda, T. Hamamoto, and T. Nakagaki A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor- cleaving protease? J Biochem 130 2001 475 480
2. G.G. Levy, W.C. Nichols, E.C. Lian, T. Foroud, J.N. McClintick, and B.M. McGee Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura Nature 413 2001 488 494
3. X. Zheng, D. Chung, T.K. Takayama, E.M. Majerus, J.E. Sadler, and K. Fujikawa Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura J Biol Chem 276 2001 41059 41063
4. K. Fujikawa, H. Suzuki, B. McMullen, and D. Chung Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family Blood 98 2001 1662 1666
5. H.E. Gerritsen, R. Robles, B. Lammle, and M. Furlan Partial amino acid sequence of purified von Willebrand factor-cleaving protease Blood 98 2001 1654 1661
6. K. Kokame, M. Matsumoto, K. Soejima, H. Yagi, H. Ishizashi, and M. Funato Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity Proc Natl Acad Sci USA 99 2002 11902 11907
7. M. Matsumoto, H. Yagi, H. Ishizashi, H. Wada, and Y. Fujimura The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Semin Hematol 41 2004 68 74
8. J.L. Moake, C.K. Rudy, J.H. Troll, M.J. Weinstein, N.M. Colannino, and J. Azocar Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura N Engl J Med 307 1982 1432 1435
9. T.W. Chow, N.A. Turner, M. Chintagumpala, P.D. McPherson, L.H. Nolasco, and L. Rice Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura Am J Hematol 57 1998 293 302
10. D.D. Wagner Cell biology of von Willebrand factor Annu Rev Cell Biol 6 1990 217 246
11. A. Borchiellini, K. Fijnvandraat, and J.W. ten Cate Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D- vasopressin in humans Blood 88 1996 2951 2958
12. B. Augusto Federici: VWF propeptide: a useful marker in VWD Blood 108 2006 3229 3230
13. N. Ito-Habe, H. Wada, T. Matsumoto, K. Ohishi, H. Toyoda, and E. Ishikawa Katayama N Elevated Von Willebrand factor propeptide for the diagnosis of thrombotic microangiopathy and for predicting a poor outcome Int J Hematol 93 2011 47 52
14. H. Wada Disseminated intravascular coagulation Clin Chim Acta 344 2004 13 21
15. T. Ono, J. Mimuro, S. Madoiwa, K. Soejima, Y. Kashiwakura, and A. Ishiwata Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure Blood 107 2006 528 534
16. J. Hyun, H.K. Kim, J.E. Kim, M.G. Lim, J.S. Jung, and S. Park Correlation between plasma activity of ADAMTS-13 and coagulopathy, and prognosis in disseminated intravascular coagulation Thromb Res 124 2009 75 79
17. F.B. Taylor Jr., C.H. Toh, K. Hoots, H. Wada, and M. Levi Towards a definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation Thromb Haemost 86 2001 1327 1330
18. N. Ito-Habe, H. Wada, M. Matsumoto, Y. Fujimura, M. Murata, and T. Izuno A second national questionnaire survey of TMA Int J Hematol 92 2010 68 75
19. H. Wada, H. Asakura, K. Okamoto, T. Iba, T. Uchiyama, and K. Kawasugi Japanese Society of Thrombosis Hemostasis/DIC subcommittee: Expert consensus for the treatment of disseminated intravascular coagulation in Japan Thromb Res 125 2010 6 11
20. K. Kokame, Y. Nobe, Y. Kokubo, A. Okayama, and T. Miyata FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay Br J Haematol 129 2005 93 100
21. T. Kobayashi, H. Wada, M. Usui, H. Sakurai, T. Matsumoto, and T. Nobori Decreased ADAMTS13 Levels in Patients after Living Donor Liver Transplantation Thromb Res 124 2009 541 545
22. M.A. Elliott, and W.L. Nichols Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Mayo Clin Proc 76 2001 1154 1162